Ping An Biomedical Co., Ltd. Cost of Revenue
Ping An Biomedical Co., Ltd. (PASW) reported Cost of Revenue of CNY 33.20 million for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-30.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-01-30
CNY
| Period end | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|
| 2025-09-30 | 33.20M CNY 20-F · filed 2026-01-30 | |
| 2025-03-31 | 18.92M CNY 6-K · filed 2025-09-29 | |
| 2024-09-30 | 82.21M CNY 20-F · filed 2026-01-30 | |
| 2024-03-31 | 42.04M CNY 6-K · filed 2025-09-29 | |
| 2023-09-30 | 78.32M CNY 20-F · filed 2026-01-30 |
USD
| Period end | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|
| 2025-09-30 | $4.66M 20-F · filed 2026-01-30 | |
| 2025-03-31 | $2.61M 6-K · filed 2025-09-29 |